MARKET

KRYS

KRYS

Krystal Biotech
NASDAQ
308.52
+9.97
+3.34%
Opening 10:10 11/18 EST
OPEN
297.60
PREV CLOSE
298.55
HIGH
309.99
LOW
297.60
VOLUME
31.75K
TURNOVER
--
52 WEEK HIGH
382.54
52 WEEK LOW
202.99
MARKET CAP
9.14B
P/E (TTM)
41.92
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KRYS last week (1109-1113)?
Weekly Report · 2d ago
Krystal Biotech Earnings Call Signals Durable Growth and Pipeline Progress
TipRanks · 3d ago
How $400 Million Buyback Will Impact Krystal Biotech (KRYS) Stock
Simply Wall St · 5d ago
Krystal Biotech (KRYS), What Is Behind The Fresh Attention?
Simply Wall St · 6d ago
Weekly Report: what happened at KRYS last week (1102-1106)?
Weekly Report · 11/09 10:10
What Early Krystal Biotech Buyers Saw
Simply Wall St · 11/07 07:35
Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM), Sarepta Therapeutics (SRPT) and Krystal Biotech (KRYS)
TipRanks · 11/06 14:31
How Investors Are Reacting To Krystal Biotech (KRYS) Earnings Beat And Buyback
Simply Wall St · 11/05 05:29
More
About KRYS
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. The Company is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.

Webull offers Krystal Biotech Inc stock information, including NASDAQ: KRYS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRYS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRYS stock methods without spending real money on the virtual paper trading platform.